Evaluating the Clinical Efficacy of Resveratrol in Improving Metabolic and Skeletal Muscle Function in Patients With Heart Failure
Evaluating the Clinical Efficacy of Resveratrol in Improving Metabolic and Skeletal Muscle Function in Patients With Heart Failure
NCT ID: NCT03525379 Phase: PHASE2 Status: COMPLETED Enrollment: 13 Completion: 2019-10-08
Conditions
Congestive Heart Failure Chronic
Interventions
Resveratrol, Placebo
Summary
This is a randomized, double-blind, placebo-controlled trial evaluating the effect of resveratrol on metabolic and skeletal muscle function. Patients will be randomized and allocated to either resveratrol or placebo, for 8 weeks with a 2-week run-in period before the intervention period (to ensure they are not on any nutritional supplement that contains resveratrol).
Primary Outcome
Change in Isolated Skeletal Muscle Blood Flow